EvaluatePharma is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors. Information includes sales by indication, licensing deals, merger & acquisitions, venture financing, IPOs, and orphaned drugs.
Technical Notes:Accounts must be requested from EvaluatePharma. Details available after iMpact login.
Accounts expire at the end of Winter term
Technical note:If you encounter a login screen, all seats are in use. Try connecting at a later time. Subscription includes 25 seats which are shared across all 3 UM campuses.